Purple Biotech Ownership | Who Owns Purple Biotech?

Purple Biotech Ownership Summary

Purple Biotech is owned by 1.99% insiders, and 98.01% retail investors. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in Purple Biotech shares.

PPBT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Purple Biotech	-	1.99%	98.01%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	1	-	15	-	-	79500.00%	-	-	-	-100.00%
Sep 30, 2024	1	-95.24%	15	-100.00%	-	-	-	-100.00%	1	-66.67%
Jun 30, 2024	21	-4.55%	1,906,869	-27.70%	7	6.41%	7	-36.36%	3	-
Mar 31, 2024	22	10.00%	2,637,428	8.39%	10	8.63%	11	10.00%	3	50.00%
Dec 31, 2023	20	5.26%	2,433,294	888.54%	11	811.54%	10	66.67%	2	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	633.00	0.04%	-

PPBT Ownership FAQ

Who Owns Purple Biotech?

Purple Biotech shareholders are primarily institutional investors at 0%, followed by 1.99% insiders and 0% retail investors. The average institutional ownership in Purple Biotech's industry, Biotech Stocks , is 68.48%, which Purple Biotech falls below.

Does Blackrock own Purple Biotech?

BlackRock is not among the top 10 institutional shareholders of Purple Biotech.

Who is the top mutual fund holder of Purple Biotech shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Purple Biotech shares, with 0.04% of its total shares outstanding invested in 633 Purple Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools